HRC Medical Centers, Inc., Don Hale, Dan Hale, D.O., and HRC Management Midwest, among other things, allegedly withheld important information about health risks and side effects from consumers and made a series of false, deceptive, and/or unsubstantiated claims about their alternative regimen of "bio-identical" hormone replacement therapy. The State's TCPA action concerns the Defendants' advertising, sales, and contractual practices. In addition, the State is seeking to have a third-party take full legal control of HRC Medical Centers, Inc. and to have a court dissolve the company.
On August 31, 2015, the Court granted in part and denied in part the State's Motion for Partial Summary Judgment. The Court found that HRC Medical Centers, Inc., Defendant Dan Hale, and Defendant Don Hale violated the TCPA by deceptively claiming that their "bio-identical" hormone replacement therapy was absolutely or completely safe, had no side effects, and restored a user's hormones to prime levels. The Court also found that Defendants HRC Medical Centers, Inc., Dan Hale, and Don Hale violated the TCPA by falsely claiming that the compounding pharmacy they used to supply their regimen of BHRT was approved by the U.S. Food and Drug Administration and by omitting the material connections to the company in consumer testimonials (e.g. ownership of the company, employment by the company, and payments from the company).
This list includes only significant filings and is not intended to be a complete record of the matter.